Screener
Recursion Pharmaceuticals, Inc. RXRX Financing Cash Flow
Financing Cash Flow at other companies
Other financials
Where this comes from
Reported directly by Recursion Pharmaceuticals, Inc. in its filing.
Tagged under the XBRL concept us-gaap:NetCashProvidedByUsedInFinancingActivities.
The source filing: Recursion Pharmaceuticals, Inc.’s 10-Q, filed August 5, 2026.
- Filed
- Aug 5, 2026, 6:32 AM EDT
- Fiscal quarter
- Q2 FY2026
- Calendar quarter
- Q2 2026
- Accession
- 0001601830-26-000098
| Line item | Six months ended June 30, 2026 | Six months ended June 30, 2025 |
|---|---|---|
| Equity incentive plans | (278) | 4,293 |
| Repayment of long-term debt and finance lease liabilities | (4,459) | (4,131) |
| Purchase of an intangible asset | — | (3,000) |
| Net cash provided by (used in) financing activities | (4,737) | 138,186 |
| Effect of exchange rate changes on cash, cash equivalents and restricted cash | (3,019) | 14,088 |
| Net change in cash, cash equivalents and restricted cash | (197,101) | (69,179) |
| Cash, cash equivalents and restricted cash, beginning of period | 753,921 | 603,024 |
| Cash, cash equivalents and restricted cash, end of period | $556,820 | $533,845 |
Item 1. Financial Statements (unaudited)
FAQ
- What is Recursion Pharmaceuticals, Inc.'s financing cash flow?
- Recursion Pharmaceuticals, Inc. (RXRX) reported financing cash flow of -$1.27M in Q2 2026.
- How has Recursion Pharmaceuticals, Inc.'s financing cash flow changed year-over-year?
- Recursion Pharmaceuticals, Inc.'s financing cash flow decreased by 101.3% year-over-year, from $97.66M to -$1.27M.
- What is the long-term trend for Recursion Pharmaceuticals, Inc.'s financing cash flow?
- Over 4 years (2021 to 2025), Recursion Pharmaceuticals, Inc.'s financing cash flow has grown at a 2.7% compound annual growth rate (CAGR), from $469.64M to $521.53M.
- What does financing cash flow mean?
- Total net cash provided by or used in financing activities — debt issuance/repayment, equity transactions, and dividend payments.
Ask your AI about Recursion Pharmaceuticals, Inc.'s financing cash flow.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude